PRAXPraxis Precision Medicines, Inc.

$7B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$154M

Operating Income

-$215M

Net Income

-$214M

EPS (Diluted)

$-69.33

Cash Flow

Operating Cash Flow

-$185M

Free Cash Flow

-$185M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$115M

Total Liabilities

$39M

Stockholders' Equity

$76M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$154M	$0	—
Operating Income	-$215M	-$167M	-28.5%
Net Income	-$214M	-$167M	-28.1%

PRAX FY 2022 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena